|Trade names||Psorcon, Florone, others|
|Drug class||Topical steroid|
|Main uses||Atopic dermatitis, psoriasis, allergic contact dermatitis|
|Side effects||Irritation, folliculitis, acne, decreased pigmentation, perioral dermatitis, infection, increased hair, striae|
|US NLM||Diflorasone diacetate|
|Chemical and physical data|
|Molar mass||494.532 g·mol−1|
Common side effects include irritation, folliculitis, acne, decreased pigmentation, perioral dermatitis, infection, increased hair, and striae. Other side effects may include Cushing's syndrome and allergic reactions. Safety in pregnancy is unclear. The strength in the United States is classified as group III.
It may be used once to four times per day.
Little data is available regarding whether diflorasone diacetate would be present in great enough quantities to cause harm to a infant.
Society and culture
It is manufactured by E. Fougera & Co.
- "Diflorasone Monograph for Professionals". Drugs.com. Archived from the original on 19 January 2021. Retrieved 28 December 2021.
- "Topical Corticosteroids: Overview". 9 July 2021. Archived from the original on 19 August 2021. Retrieved 28 December 2021.
- "Diflorasone Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 12 May 2016. Retrieved 28 December 2021.
- "Diflorasone topical". Drugs.com. Archived from the original on 2020-11-17. Retrieved 2020-11-12.